Literature DB >> 10877317

Graphical exploration of covariate effects on survival data through nonparametric quantile curves.

A W Bowman1, E M Wright.   

Abstract

Kaplan-Meier curves provide an effective means of presenting the distributional pattern in a sample of survival data. However, in order to assess the effect of a covariate, a standard scatterplot is often difficult to interpret because of the presence of censored observations. Several authors have proposed a running median as an effective way of indicating the effect of a covariate. This article proposes a form of kernel estimation, employing double smoothing, that can be applied in a simple and efficient manner to construct an estimator of a percentile of the survival distribution as a function of one or two covariates. Permutations and bootstrap samples can be used to construct reference bands that help identify whether particular features of the estimates indicate real features of the underlying curve or whether this may be due simply to random variation. The techniques are illustrated on data from a study of kidney transplant patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877317     DOI: 10.1111/j.0006-341x.2000.00563.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  2 in total

1.  Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.

Authors:  Sarp K Keskin; Pavlos Msaouel; Kenneth R Hess; Kai-Jie Yu; Surena F Matin; Kanishka Sircar; Pheroze Tamboli; Eric Jonasch; Christopher G Wood; Jose A Karam; Nizar M Tannir
Journal:  J Urol       Date:  2017-04-11       Impact factor: 7.450

2.  A strategy for full interrogation of prognostic gene expression patterns: exploring the biology of diffuse large B cell lymphoma.

Authors:  Lisa M Rimsza; Joseph M Unger; Margaret E Tome; Michael L Leblanc
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.